OVERVIEW

P21 (also known as P021) 5mg is an experimental synthetic peptide derived from a fragment of ciliary neurotrophic factor (CNTF). It has been studied primarily in preclinical research for its potential neuroprotective and cognitive-support properties. P021 is designed to enhance the expression of brain-derived neurotrophic factor (BDNF), a protein that plays a key role in neuronal growth, synaptic plasticity, and memory formation. By influencing pathways involved in neurogenesis and cellular resilience, P021 has attracted interest in research focused on age-related cognitive decline and neurodegenerative conditions. The reference to “6000 IU” is sometimes used in product labeling, though peptides like P021 are typically measured in milligrams rather than international units.

At a 5mg dosage, P021 is generally supplied for laboratory or research purposes only, as it is not approved by major regulatory authorities for medical use. Early animal studies suggest it may support learning, memory retention, and neuronal repair mechanisms, but comprehensive human clinical trials are still lacking. As with many investigational peptides affecting the central nervous system, safety, optimal dosing, and long-term effects remain under evaluation. Because of its experimental status and biological activity, any consideration of P021 should involve careful review of current research and consultation with a qualified healthcare professional.